Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients

Secondary hyperparathyroidism (SHPTH) can develop early in the course of chronic renal failure and becomes more prominent as kidney function declines. We studied the effect of diabetes, age, and dialysis on parathyroid function in 60 (21 women, 39 males; 44 non-diabetic, 16 diabetic) hemodialysis (H...

Full description

Bibliographic Details
Main Authors: Nasri Hamid, Kheiri Soleiman
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2008-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Subjects:
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2008;volume=19;issue=4;spage=608;epage=613;aulast=Nasri
_version_ 1818907835996569600
author Nasri Hamid
Kheiri Soleiman
author_facet Nasri Hamid
Kheiri Soleiman
author_sort Nasri Hamid
collection DOAJ
description Secondary hyperparathyroidism (SHPTH) can develop early in the course of chronic renal failure and becomes more prominent as kidney function declines. We studied the effect of diabetes, age, and dialysis on parathyroid function in 60 (21 women, 39 males; 44 non-diabetic, 16 diabetic) hemodialysis (HD) patients. Serum intact PTH (iPTH), calcium, phosphorus, alkaline phosphatase (ALP), and magnesium (Mg) were measured. Adequacy of HD was evaluated by calculating the urea reduction rate (URR). There were significantly lower values of serum iPTH, ALP, and dialysis adequacy among diabetic than non-diabetes HD patients. In addition, there were an inverse correlation of age and serum iPTH (r= -0.27, p= 0.034) as well as age and serum phosphorus (r= -0.28, p= 0.031). There was also a positive correlation between serum iPTH with the duration (r= 0.001, p=0.42) and doses of dialysis treatment (r= 0.38, p= 0.002). We conclude that a significant negative correlation between age and serum phosphorus and lower parathyroid activity in diabetic HD patients, which implies more prevalence of bone disease in elderly diabetic HD patients. Further study of bone disease in this group of patients is required to evaluate its effect on outcome and different therapeutic interventions.
first_indexed 2024-12-19T22:01:27Z
format Article
id doaj.art-138048c5bc9e4f3fb68c610109717db7
institution Directory Open Access Journal
issn 1319-2442
language English
last_indexed 2024-12-19T22:01:27Z
publishDate 2008-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Saudi Journal of Kidney Diseases and Transplantation
spelling doaj.art-138048c5bc9e4f3fb68c610109717db72022-12-21T20:04:08ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422008-01-01194608613Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis PatientsNasri HamidKheiri SoleimanSecondary hyperparathyroidism (SHPTH) can develop early in the course of chronic renal failure and becomes more prominent as kidney function declines. We studied the effect of diabetes, age, and dialysis on parathyroid function in 60 (21 women, 39 males; 44 non-diabetic, 16 diabetic) hemodialysis (HD) patients. Serum intact PTH (iPTH), calcium, phosphorus, alkaline phosphatase (ALP), and magnesium (Mg) were measured. Adequacy of HD was evaluated by calculating the urea reduction rate (URR). There were significantly lower values of serum iPTH, ALP, and dialysis adequacy among diabetic than non-diabetes HD patients. In addition, there were an inverse correlation of age and serum iPTH (r= -0.27, p= 0.034) as well as age and serum phosphorus (r= -0.28, p= 0.031). There was also a positive correlation between serum iPTH with the duration (r= 0.001, p=0.42) and doses of dialysis treatment (r= 0.38, p= 0.002). We conclude that a significant negative correlation between age and serum phosphorus and lower parathyroid activity in diabetic HD patients, which implies more prevalence of bone disease in elderly diabetic HD patients. Further study of bone disease in this group of patients is required to evaluate its effect on outcome and different therapeutic interventions.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2008;volume=19;issue=4;spage=608;epage=613;aulast=NasriHemodialysisHyperparathyroidismParathormoneRenalFailureDiabetes mellitus
spellingShingle Nasri Hamid
Kheiri Soleiman
Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients
Saudi Journal of Kidney Diseases and Transplantation
Hemodialysis
Hyperparathyroidism
Parathormone
Renal
Failure
Diabetes mellitus
title Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients
title_full Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients
title_fullStr Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients
title_full_unstemmed Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients
title_short Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients
title_sort effects of diabetes mellitus age and duration of dialysis on parathormone in chronic hemodialysis patients
topic Hemodialysis
Hyperparathyroidism
Parathormone
Renal
Failure
Diabetes mellitus
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2008;volume=19;issue=4;spage=608;epage=613;aulast=Nasri
work_keys_str_mv AT nasrihamid effectsofdiabetesmellitusageanddurationofdialysisonparathormoneinchronichemodialysispatients
AT kheirisoleiman effectsofdiabetesmellitusageanddurationofdialysisonparathormoneinchronichemodialysispatients